Austin-based XBiotech Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of True Human monoclonal antibodies for treating various diseases. With a primary focus on developing a robust selection of product candidates, the company targets inflammatory and infectious diseases. XBiotech is also working on a range of interleukin-1 alpha therapies catering to an array of medical conditions. These therapies address concerns such as cancer, stroke, heart attack, arthritis, tissue breakdown, angiogenesis, blood clots, malaise, muscle wasting, and inflammation. XBiotech Inc. was founded in 2005 and operates out of Austin, Texas.
Xbiotech Inc's ticker is XBIT
The company's shares trade on the NASDAQ stock exchange
They are based in Austin, Texas
There are 51-200 employees working at Xbiotech Inc
It is http://www.xbiotech.com/
Xbiotech Inc is in the Healthcare sector
Xbiotech Inc is in the Biotechnology industry
The following five companies are Xbiotech Inc's industry peers: